KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Aurinia Pharmaceuticals (AUPH) Return on Assets (2019 - 2025)

Historic Return on Assets for Aurinia Pharmaceuticals (AUPH) over the last 10 years, with Q3 2025 value amounting to 0.15%.

  • Aurinia Pharmaceuticals' Return on Assets rose 1900.0% to 0.15% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.15%, marking a year-over-year increase of 1900.0%. This contributed to the annual value of 0.01% for FY2024, which is 1600.0% up from last year.
  • Latest data reveals that Aurinia Pharmaceuticals reported Return on Assets of 0.15% as of Q3 2025, which was up 1900.0% from 0.12% recorded in Q2 2025.
  • Aurinia Pharmaceuticals' 5-year Return on Assets high stood at 0.15% for Q3 2025, and its period low was 0.51% during Q3 2021.
  • In the last 5 years, Aurinia Pharmaceuticals' Return on Assets had a median value of 0.15% in 2023 and averaged 0.17%.
  • Its Return on Assets has fluctuated over the past 5 years, first plummeted by -600bps in 2021, then soared by 2700bps in 2022.
  • Aurinia Pharmaceuticals' Return on Assets (Quarter) stood at 0.4% in 2021, then surged by 44bps to 0.23% in 2022, then skyrocketed by 37bps to 0.14% in 2023, then soared by 107bps to 0.01% in 2024, then skyrocketed by 1357bps to 0.15% in 2025.
  • Its Return on Assets was 0.15% in Q3 2025, compared to 0.12% in Q2 2025 and 0.08% in Q1 2025.